University Health Network, Toronto: Lymphoma trials
The registry lists 17 Lymphoma studies with University Health Network, Toronto as lead sponsor. 6 are open to participants now and 0 have results posted.
Phase 1 4Phase 2 8Phase 3 1No phase 6(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Randomized Controlled TrialNot yet recruitingNCT07820033Phase 2
- Digital Peer Navigation for Adolescents and Young Adults With CancerRecruitingNCT06193369Not applicable
- Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLLRecruitingNCT05963217Phase 1
- Virtual Rehabilitation for Cancer SurvivorsRecruitingNCT05898789Not applicable
- Marathon of Hope Cancer Centres Network Study for Ontario (MOHCCN-O)RecruitingNCT05403177
- Liquid Biopsy Evaluation and Repository Development at Princess MargaretRecruitingNCT03702309
- Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced CancerActive, not recruitingNCT06416085Phase 2
- Self-Management and Activation to Reduce Treatment-Related Toxicities (SMARTCare)TerminatedNCT03849950Not applicable
- Obinutuzumab in Combination With GDP Chemotherapy in Patients With Relapsed or Refractory Non-Hodgkin LymphomaCompletedNCT02750670Phase 2
- Tenofovir to Prevent HBV ReactivationStatus unknownNCT02186574Phase 3
- Study Evaluating the Tolerance and Biological Activity of Oral Clioquinol in Patients With Relapsed or Refractory Hematological MalignancyTerminatedNCT00963495Phase 1
- Positron Emission Tomography(PET) in Lymphoma AssessmentCompletedNCT00887718Not applicable
- Phase II Study of Lenalidomide for the Treatment of Relapsed or Refractory Hodgkin's LymphomaCompletedNCT00478959Phase 2
- Reproducibility of an Immobilization Device (BodyFIX) - Hodgkins/LymphomaCompletedNCT00232440Phase 1/2
- Assessment of Treatment Response Using PET/CT Scanner - Non Hodgkin's LymphomaCompletedNCT00188929Phase 2
- Ultrasound Biomicroscopy - ApoptosisCompletedNCT00188370Phase 2
- Combination Chemotherapy in Treating Patients With Chronic Lymphocytic Leukemia or Lymphocytic LymphomaCompletedNCT00045513Phase 1/2